Today, the U.S. Food and Drug Administration authorized marketing of the first test to aid in newborn screening for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.
Read more: FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy